US enterprises should map EU AI Act exposure across products, vendors, internal AI deployments and EU-facing operations. A structured inventory and role classification should come before broad implementation work.
Operational information, not legal advice.
Company exposure map
Business context
EU customers, users or output
AI product or workflow use
Exposure path
Strategic answer
US enterprises often have AI exposure across products, vendors, internal deployments and customer workflows. EU AI Act readiness starts by mapping which systems touch EU users, EU operations, EU customers or EU-facing outputs.
Start with the EU AI Act Diagnostic, turn findings into an implementation plan, and see how the diagnostic works as a reference app on M13.
Exposure focus
First action
This page provides operational information for AI governance readiness. It is not legal advice.
Related guides
Run a diagnostic-first EU AI Act assessment for role, risk, documentation and implementation exposure.
A direct answer page for US companies that need to understand possible EU AI Act exposure.
A US company guide to EU AI Act exposure, diagnostic preparation and implementation order.
A practical guide to assessing EU AI Act risk before committing budget to implementation.
Official sources
External references are included for source orientation. This page remains operational information and is not legal advice.
